Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polycistronic viral vectors.

P de Felipe1

  • 1University of St. Andrews, Centre for Biomolecular Sciences, St. Andrews, KY16 9ST, Scotland, United Kingdom. pdf@st-andrews.ac.uk

Current Gene Therapy
|August 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

L1Tc non-LTR retrotransposons from Trypanosoma cruzi contain a functional viral-like self-cleaving 2A sequence in frame with the active proteins they encode.

Cellular and molecular life sciences : CMLS·2006
Same author

Integrating retroviral cassette extends gene delivery of HSV-1 expression vectors to dividing cells.

BioTechniques·2001
Same author

Tricistronic and tetracistronic retroviral vectors for gene transfer.

Human gene therapy·2000
Same author

Cancer gene therapy by thyroid hormone-mediated expression of toxin genes.

Cancer research·2000
Same author

Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy.

Gene therapy·1999
Same author

Successful use of a plant gene in the treatment of cancer in vivo.

Gene therapy·1999
Same journal

Identifying Basement Membrane-Related Diagnostic Biomarkers for Rheumatoid Arthritis Through Machine Learning.

Current gene therapy·2026
Same journal

A Multi-Gene Myofibroblast Framework Stratifies Prognostic and Immune Landscapes in HCC.

Current gene therapy·2026
Same journal

Single-cell Transcriptomics Inference of Neutrophil-mast Cell Communication Programs in Periodontitis.

Current gene therapy·2026
Same journal

GULP1 in Ovarian Cancer: Expression, Biological Function, and Clinical Significance.

Current gene therapy·2026
Same journal

Single‑cell Transcriptomic Profiling of Bone Marrow Mesenchymal Stem Cells Reveals Lineage Heterogeneity and Dysregulated Osteoblast Genes in Osteoporosis Versus Osteoarthritis.

Current gene therapy·2026
Same journal

Surface Functionalization of 3D-Printed Porous Ti-6Al-4V Scaffolds with PDA‑mHA-Col I Composite Coating Drives Macrophage Polarization toward the M2 Phenotype and Promotes Immunomodulation: An In Vitro Study.

Current gene therapy·2026
See all related articles

New biotechnological tools enable the creation of advanced polycistronic vectors for gene therapy. These vectors allow for the co-expression of multiple genes, offering enhanced therapeutic potential compared to traditional single-gene approaches.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Biotechnology

Background:

  • Traditional gene transfer vectors were primarily mono- or bicistronic, expressing one or two genes.
  • A growing need exists for complex polycistronic vectors to achieve enhanced gene therapy effects, inspired by combination therapies in medicine.

Purpose of the Study:

  • To describe and compare strategies for co-expressing multiple genes in bicistronic and polycistronic vectors.
  • To classify these strategies based on transcriptional or translational/post-translational mechanisms.
  • To discuss the applications and challenges of polycistronic vector design.

Main Methods:

  • Review and comparison of established and novel strategies for gene co-expression.
  • Classification of strategies into transcriptional (multiple transcripts) and translational/post-translational (single transcript) mechanisms.

Related Experiment Videos

  • Examination of polycistronic vector construction attempts and associated problems.

    • Main Results:

    • Identified and compared various co-expression strategies including internal promoters, splicing, reinitiation, IRES, self-processing peptides, and proteolytic cleavage sites.
    • Proposed a classification system for these strategies.
    • Highlighted challenges in constructing functional polycistronic vectors.

    Conclusions:

    • Advances in biotechnology have significantly improved the design of reliable bicistronic and polycistronic vectors.
    • Polycistronic vectors hold considerable promise for basic research and therapeutic applications.
    • Understanding viral gene expression is crucial for advancing vector design in gene therapy.